
An advanced third-generation cephalosporin prodrug (CAS 87239-81-4) designed for superior oral absorption and broad-spectrum antimicrobial activity.
Maximum molecular purity and strict batch traceability provide an essential competitive edge for international manufacturing plants creating advanced medical formulas. This synthetic ester derivative works by inhibiting bacterial cell wall synthesis during active multiplication, ensuring a stable bactericidal effect without disrupting non-target chemical matrices. It helps technical formulators achieve uniform biological profiles in large-scale tablet and capsule production lines. For instance, Cefpodoxime Proxetil serves as the core therapeutic standard for treating highly resistant microbial strains in modern clinical settings. Consequently, integrating this premium chemical agent elevates the baseline quality and standard compliance of your final commercial batch. As a result, Zyntex enforces strict validation testing for every single distribution lot, ensuring ultimate batch continuity.
Moreover, Zyntex maintains specialized storage protocols required to protect sensitive beta-lactam rings during international distribution. This pharmaceutical intermediate plays an irreplaceable role in advanced organic synthesis, serving as a reliable benchmark for studying modern enzyme kinetics and complex beta-lactamase resistance patterns. It opens new possibilities for custom formulation trials by operating as a precise building block for specialized solutions and academic biochemical research projects. At the same time, it remains a critical chemical standard for testing structural bio-identity and checking degradation limits over extended storage timelines. In short, our product operates as a highly trustworthy active antibiotic source, safeguarding both structural compound longevity and technical manufacturing precision.
Recently, academic interest regarding its role in advanced pediatric oral suspension designs and taste-masking matrix technologies has grown tremendously. It offers a clean and predictable chemical foundation for discovering alternative medical solutions for sensitive patient demographic matrices. Because of this, Zyntex offers refined, low-impurity grades specifically created to satisfy the detailed regulatory requirements of modern clinical facilities worldwide. Ultimately, selecting Zyntex guarantees a reliable, fully documented, and robust raw material channel. We successfully blend industry-focused chemical logistics with strict global quality assessments. To conclude, our operational dedication ensures that your industrial processing applications retain the highest possible molecular accuracy and chemical purity.
This high-purity active pharmaceutical ingredient is crucial across these four primary chemical sectors:
Primary active ingredient for film-coated tablets and hard gelatin capsules. Thus, it ensures reliable therapeutic delivery.
Excellent option for dry powder formulations requiring precise taste-masking. Undoubtedly, it supports localized stability.
Cost-effective, highly stable bioequivalent standard for international generic lines. Consequently, it accelerates development pipelines.
Core reference material for evaluating third-generation cephalosporin susceptibility profiles. Specifically, it maintains testing accuracy.
| Parameter | Standard Value |
|---|---|
| Product Name | Cefpodoxime Proxetil |
| Molecular Formula | C21H27N5O9S2 |
| Assay (Purity) | ≥ 98.0% (on anhydrous basis) |
| CAS Number | 87239-81-4 |
📝 Safety & Handling: Cefpodoxime Proxetil may cause allergic sensitization or hypersensitivity reactions upon direct inhalation or exposure. Therefore, store in tightly closed containers in a cool, dry, well-ventilated warehouse facility. Avoid dust accumulation and direct mucosal contact. Wear standard pharmaceutical PPE including protective gloves, dust masks, and safety goggles during handling operations. Always review the detailed Safety Data Sheet (SDS) for environmental protocols.